Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

Figure 2

Overall survival in correlation to circulating tumor cell (CTC) detection with the CellSearch™ system subdivided by type of the primary tumor. (a) For 'luminal' type, for example, hormone receptor-positive and HER2-negative. (b) For HER2-positive. (c) For triple-negative primary tumors. HER2, human epidermal growth factor receptor 2.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us